{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:16:52Z","timestamp":1776809812584,"version":"3.51.2"},"reference-count":34,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T00:00:00Z","timestamp":1415318400000},"content-version":"unspecified","delay-in-days":4238,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS spectr."],"published-print":{"date-parts":[[2003,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Depression in children and adolescents is relatively common and associated with significant morbidity and mortality\u2014thus, it is strongly deserving of treatment. To date, there have been a number of randomized, controlled trials of both tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) in the acute treatment of depression in youths. Surprisingly, the available data do not demonstrate TCA superiority over placebo for this disorder in this age group. There is, however, evidence of SSRI superiority to placebo, and longer-term treatment with SSRIs may help prevent recurrence. There is almost no data on other pharmacologic approaches. Effective use of the efficacious treatments also depends on effective case-finding and providing treatment, which families and youths will take in adequate quantity and duration. The right approaches to these aspects of effective treatment are greatly understudied.<\/jats:p>","DOI":"10.1017\/s1092852900018496","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T03:25:45Z","timestamp":1470108345000},"page":"283-287","source":"Crossref","is-referenced-by-count":18,"title":["Medication Treatment for Depression in Children and Adolescents"],"prefix":"10.1017","volume":"8","author":[{"given":"Neal D.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,11,7]]},"reference":[{"key":"S1092852900018496_ref018","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199201000-00005"},{"key":"S1092852900018496_ref029","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198811000-00016"},{"key":"S1092852900018496_ref007","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70014-9"},{"key":"S1092852900018496_ref024","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1176\/ajp.154.5.668","article-title":"Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial","volume":"154","author":"Sallee","year":"1997","journal-title":"Am J Psychiatry"},{"key":"S1092852900018496_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(90)90050-Q"},{"key":"S1092852900018496_ref027","unstructured":"Wagner KD , Robb AS , Findling R , Tiseo PJ . Citalopram is effective in the treatment of major depressive disorder in children and adolescents: results of a placebo-controlled trial. Paper presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 9-13, 2001; Waikaloa, HI."},{"key":"S1092852900018496_ref001","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-7138(09)61021-9"},{"key":"S1092852900018496_ref017","first-page":"85","article-title":"Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a \u201cfixed plasma level\u201d design","volume":"26","author":"Geller","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"S1092852900018496_ref014","first-page":"101","article-title":"Double-blind, placebo-controlled study of nortriptyline in depressed children using a \u201cfixed plasma level\u201d design","volume":"25","author":"Geller","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"S1092852900018496_ref012","first-page":"128","article-title":"Depression in prepubertal children: dexamethasone nonsuppression predicts differential response to imipramine vs. placebo","volume":"23","author":"Preskorn","year":"1987","journal-title":"Psychopharmacol Bull"},{"key":"S1092852900018496_ref020","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199609000-00011"},{"key":"S1092852900018496_ref026","unstructured":"Emslie GJ , Heiligenstein JH , Hoog SL , et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. Paper presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 10-14, 2000; San Juan, Puerto Rico."},{"key":"S1092852900018496_ref032","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01149-0"},{"key":"S1092852900018496_ref030","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198805000-00018"},{"key":"S1092852900018496_ref005","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810050020005"},{"key":"S1092852900018496_ref031","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199201000-00004"},{"key":"S1092852900018496_ref002","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1987.01800220016003"},{"key":"S1092852900018496_ref003","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790140019002"},{"key":"S1092852900018496_ref004","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790180013001"},{"key":"S1092852900018496_ref006","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199512000-00010"},{"key":"S1092852900018496_ref008","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7144.1559"},{"key":"S1092852900018496_ref009","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.178.3.234"},{"key":"S1092852900018496_ref010","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198204000-00004"},{"key":"S1092852900018496_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-7138(09)60515-X"},{"key":"S1092852900018496_ref013","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1987.01800130093012"},{"key":"S1092852900018496_ref015","first-page":"235","article-title":"The effect of concomitant disorders in childhood depression on predicting treatment response","volume":"26","author":"Hughes","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"S1092852900018496_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-7138(09)61650-2"},{"key":"S1092852900018496_ref019","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199406000-00010"},{"key":"S1092852900018496_ref021","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200107000-00010"},{"key":"S1092852900018496_ref022","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199612000-00008"},{"key":"S1092852900018496_ref028","unstructured":"Donnelly CL , Winokur A , Wohlberg CJ . Efficacy and safety of sertraline in the treatment of pediatric major depressive disorder. Paper presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 9-13, 2001; Waikaloa, HI."},{"key":"S1092852900018496_ref033","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.87.11.1773"},{"key":"S1092852900018496_ref034","first-page":"195","article-title":"The Tuskegee Syphilis Study and women's health","volume":"52","author":"Gamble","year":"1997","journal-title":"J Am Med Womens Assoc"},{"key":"S1092852900018496_ref025","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830230069010"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852900018496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T23:22:18Z","timestamp":1557184938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852900018496\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["S1092852900018496"],"URL":"https:\/\/doi.org\/10.1017\/s1092852900018496","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}